143 related articles for article (PubMed ID: 24531694)
1. Active ulcerative colitis diagnosed by (18)F-FDG PET/CT in an anti-TNF alpha treated patient with no visible luminal lesions on colonoscopy.
Parbo P; Stribolt K; Rittig CS; Gormsen LC
Int J Colorectal Dis; 2014 May; 29(5):643-4. PubMed ID: 24531694
[No Abstract] [Full Text] [Related]
2. TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: a case report and literature review.
Ben Musa R; Usha L; Hibbeln J; Mutlu EA
World J Gastroenterol; 2014 May; 20(19):5912-7. PubMed ID: 24914353
[TBL] [Abstract][Full Text] [Related]
3. Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab.
Armuzzi A; Pugliese D; Nardone OM; Guidi L
Drug Des Devel Ther; 2013; 7():289-96. PubMed ID: 23630414
[TBL] [Abstract][Full Text] [Related]
4. Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis.
Stidham RW; Lee TC; Higgins PD; Deshpande AR; Sussman DA; Singal AG; Elmunzer BJ; Saini SD; Vijan S; Waljee AK
Aliment Pharmacol Ther; 2014 Apr; 39(7):660-71. PubMed ID: 24506179
[TBL] [Abstract][Full Text] [Related]
5. Polymyalgia rheumatica as presenting manifestation of vasculitis involving the lower extremities in a patient with ulcerative colitis.
Bejerano C; Blanco R; González-Vela C; Pérez-Martín I; Martinez-Rodriguez I; Jimenez-Bonilla J; González-Gay MA
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S110-3. PubMed ID: 22640654
[TBL] [Abstract][Full Text] [Related]
6. Positioning Therapy for Ulcerative Colitis.
Grinspan A; Kornbluth A
Curr Gastroenterol Rep; 2015 Aug; 17(8):29. PubMed ID: 26143627
[TBL] [Abstract][Full Text] [Related]
7. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R
Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative Colitis in Adults.
Glick LR; Cifu AS; Feld L
JAMA; 2020 Sep; 324(12):1205-1206. PubMed ID: 32857108
[No Abstract] [Full Text] [Related]
9. Clinical relevance of incidental finding of focal uptakes in the colon during 18F-FDG PET/CT studies in oncology patients without known colorectal carcinoma and evaluation of the impact on management.
Salazar Andía G; Prieto Soriano A; Ortega Candil A; Cabrera Martín MN; González Roiz C; Ortiz Zapata JJ; Cardona Arboniés J; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):15-21. PubMed ID: 21640441
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists.
Tursi A; Elisei W; Picchio M; Giorgetti G; Brandimarte G
Dig Dis Sci; 2015 May; 60(5):1406-13. PubMed ID: 25445163
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Escalation to weekly dosing in adalimumab-treated patients with active ulcerative colitis.
Ward MG; Sparrow MP
Aliment Pharmacol Ther; 2014 Sep; 40(6):730-1. PubMed ID: 25123387
[No Abstract] [Full Text] [Related]
12. Adalimumab-Receiving Ulcerative Colitis Patient Suffered Latent Tuberculosis Reactivation Despite Correct Chemoprophylaxis and was Successfully Treated while on Anti-Tumour Necrosis Factor Therapy.
Agudo B; Díaz G; González-Lama Y
J Crohns Colitis; 2016 Dec; 10(12):1453-1454. PubMed ID: 27215554
[No Abstract] [Full Text] [Related]
13. One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2.
Sandborn WJ; Colombel JF; D'Haens G; Van Assche G; Wolf D; Kron M; Lazar A; Robinson AM; Yang M; Chao JD; Thakkar R
Aliment Pharmacol Ther; 2013 Jan; 37(2):204-13. PubMed ID: 23173821
[TBL] [Abstract][Full Text] [Related]
14. An update on anti-TNF agents in ulcerative colitis.
Samaan MA; Bagi P; Vande Casteele N; D'Haens GR; Levesque BG
Gastroenterol Clin North Am; 2014 Sep; 43(3):479-94. PubMed ID: 25110254
[TBL] [Abstract][Full Text] [Related]
15. Interactive medical case. A man with diarrhea and back pain.
Schorr M; Vaidya A; Schulte S; Todd DJ; Conant A
N Engl J Med; 2015 Apr; 372(15):e21. PubMed ID: 25853769
[No Abstract] [Full Text] [Related]
16. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ; van Assche G; Reinisch W; Colombel JF; D'Haens G; Wolf DC; Kron M; Tighe MB; Lazar A; Thakkar RB
Gastroenterology; 2012 Feb; 142(2):257-65.e1-3. PubMed ID: 22062358
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab in ulcerative colitis: ready for prime time.
Danese S
Dig Liver Dis; 2013 Jan; 45(1):8-13. PubMed ID: 22766323
[TBL] [Abstract][Full Text] [Related]
18. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-A therapy about infliximab and adalimamab for the effectiveness in ulcerative colitis compared with conventional therapy: a meta-analysis.
Zhou Z; Dai C; Liu WX
Hepatogastroenterology; 2015; 62(138):309-18. PubMed ID: 25916055
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting.
Trinder MW; Lawrance IC
J Gastroenterol Hepatol; 2009 Jul; 24(7):1252-7. PubMed ID: 19220669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
